
EU approves Pfizer/BioNTech’s Covid vaccine for children
European Union’s drug regulator European Medicines Agency has on Thursday recommended that Pfizer/BioNTech’s anti-Covid booster vaccine be approved for children aged 12 and older.
European Union’s drug regulator European Medicines Agency has on Thursday recommended that Pfizer/BioNTech’s anti-Covid booster vaccine be approved for children aged 12 and older.